368 related articles for article (PubMed ID: 28388561)
21. Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine.
Lin JT; Tsai KW
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924142
[TBL] [Abstract][Full Text] [Related]
22. Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study.
Spagnuolo M; Costantini M; Ferriero M; Varmi M; Sperduti I; Regazzo G; Cicchillitti L; Díaz Méndez AB; Cigliana G; Pompeo V; Russo A; Laquintana V; Mastroianni R; Piaggio G; Anceschi U; Brassetti A; Bove A; Tuderti G; Flammia RS; Gallucci M; Simone G; Rizzo MG
J Exp Clin Cancer Res; 2020 Apr; 39(1):68. PubMed ID: 32303246
[TBL] [Abstract][Full Text] [Related]
23. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
[TBL] [Abstract][Full Text] [Related]
24. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
[TBL] [Abstract][Full Text] [Related]
25. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.
Juracek J; Peltanova B; Dolezel J; Fedorko M; Pacik D; Radova L; Vesela P; Svoboda M; Slaby O; Stanik M
J Cell Mol Med; 2018 Mar; 22(3):2033-2038. PubMed ID: 29363887
[TBL] [Abstract][Full Text] [Related]
27. MiR-188-5p and MiR-141-3p influence prognosis of bladder cancer and promote bladder cancer synergistically.
Yang X; Wang P
Pathol Res Pract; 2019 Nov; 215(11):152598. PubMed ID: 31562019
[TBL] [Abstract][Full Text] [Related]
28. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
29. Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer.
Yun SJ; Jeong P; Kim WT; Kim TH; Lee YS; Song PH; Choi YH; Kim IY; Moon SK; Kim WJ
Int J Oncol; 2012 Nov; 41(5):1871-8. PubMed ID: 22961325
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.
Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L
Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929
[TBL] [Abstract][Full Text] [Related]
31. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W
Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.
Wang J; Zhang X; Wang L; Dong Z; Du L; Yang Y; Guo Y; Wang C
J Surg Oncol; 2015 Jun; 111(8):992-9. PubMed ID: 25975233
[TBL] [Abstract][Full Text] [Related]
33. Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.
Matsushita R; Seki N; Chiyomaru T; Inoguchi S; Ishihara T; Goto Y; Nishikawa R; Mataki H; Tatarano S; Itesako T; Nakagawa M; Enokida H
Br J Cancer; 2015 Jul; 113(2):282-9. PubMed ID: 26057453
[TBL] [Abstract][Full Text] [Related]
34. Urine cell-based DNA methylation classifier for monitoring bladder cancer.
van der Heijden AG; Mengual L; Ingelmo-Torres M; Lozano JJ; van Rijt-van de Westerlo CCM; Baixauli M; Geavlete B; Moldoveanud C; Ene C; Dinney CP; Czerniak B; Schalken JA; Kiemeney LALM; Ribal MJ; Witjes JA; Alcaraz A
Clin Epigenetics; 2018; 10():71. PubMed ID: 29854012
[TBL] [Abstract][Full Text] [Related]
35. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
[TBL] [Abstract][Full Text] [Related]
36. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
Eissa S; Matboli M; Essawy NO; Kotb YM
Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586
[TBL] [Abstract][Full Text] [Related]
37. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
[TBL] [Abstract][Full Text] [Related]
38. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer.
Pignot G; Cizeron-Clairac G; Vacher S; Susini A; Tozlu S; Vieillefond A; Zerbib M; Lidereau R; Debre B; Amsellem-Ouazana D; Bieche I
Int J Cancer; 2013 Jun; 132(11):2479-91. PubMed ID: 23169479
[TBL] [Abstract][Full Text] [Related]
39. Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer.
Jiang X; Wang W; Yang Y; Du L; Yang X; Wang L; Zheng G; Duan W; Wang R; Zhang X; Wang L; Chen X; Wang C
Oncotarget; 2017 Sep; 8(39):65132-65142. PubMed ID: 29029418
[TBL] [Abstract][Full Text] [Related]
40. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
